Y. Ito et al., LITTLE EXPRESSION OF PROTOONCOGENE BCL-2 IN TUMOROUS CELLS OF HEPATOCELLULAR-CARCINOMA WITH CHRONIC HEPATITIS-C VIRUS-INFECTION, HEPATOLOGY RESEARCH, 4(6), 1996, pp. 316-325
The proto-oncogene bcl-2, which was first found overexpressed in human
follicular lymphoma, is now considered to inhibit apoptotic cell deat
h, resulting in greater cell susceptibility to genetic alteration. Thu
s, this gene might cause hyperplasia or occasionally lead to a more ma
lignant phase, i.e. carcinoma. Overexpression of this gene has been re
ported in several tumors. However, little has been clarified about its
contribution to hepatocarcinogenesis. In this study, using immunoblot
ting, immunohistochemical and in situ hybridization techniques, we exa
mined the expression of the bcl-2 protein and messenger RNA in patient
s having hepatocellular carcinoma with chronic hepatitis C virus infec
tion. Immunoblot analysis indicated no significant differences in the
amounts of bcl-2 protein between tumorous and nontumorous lesions. Fur
thermore, immunohistochemistry as well as in situ hybridization techni
que demonstrated that only lymphocytes infiltrating the tissues and tu
mors were bcl-2 positive. These findings suggest that the proto-oncoge
ne bcl-2 may make no or little contribution, if any, to hepatocarcinog
enesis.